Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phillip Minar

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Alimentary Pharmacology & Therapeutics|December 22, 2021
Antibodies-to-infliximab accelerate clearance while dose intensification reverses immunogenicity and recaptures clinical response in paediatric Crohn's diseaseRuben J Colman, Ye Xiong, Tomoyuki Mizuno, et al.
Inflammatory Bowel Diseases|May 23, 2024
Challenges in IBD Research 2024: Pragmatic Clinical ResearchJessica R Allegretti, Liliana G Bordeianou, Oriana M Damas, et al.
Alimentary Pharmacology & Therapeutics|October 31, 2022
Real world population pharmacokinetic study in children and young adults with inflammatory bowel disease discovers novel blood and stool microbial predictors of vedolizumab clearanceRuben J Colman, Tomoyuki Mizuno, Keizo Fukushima, et al.
Inflammatory Bowel Diseases|August 28, 2015
IL-33 Signaling Protects from Murine Oxazolone Colitis by Supporting Intestinal Epithelial FunctionAmanda Waddell, Jefferson E Vallance, Preston D Moore, et al.
Haematologica|February 2, 2023
Transcriptome analysis in acute gastrointestinal graft-<i>versus</i> host disease reveals a unique signature in children and shared biology with pediatric inflammatory bowel diseasePooja Khandelwal, Dana T Lounder, Allison Bartlett, et al.
Inflammatory Bowel Diseases|May 3, 2014
Utility of neutrophil Fcγ receptor I (CD64) index as a biomarker for mucosal inflammation in pediatric Crohn's diseasePhillip Minar, Yael Haberman, Ingrid Jurickova, et al.
European Radiology|March 23, 2025
Magnetic resonance imaging for suspected perianal Crohn's disease in children: a multi-reader agreement studyPradipta Debnath, Michael R Acord, Christopher G Anton, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 28, 2022
Multicenter Cohort Study of Infliximab Pharmacokinetics and Therapy Response in Pediatric Acute Severe Ulcerative ColitisKaitlin G Whaley, Ye Xiong, Rebekah Karns, et al.
Journal of Crohn'S & Colitis|June 6, 2022
Targeted Assessment of Mucosal Immune Gene Expression Predicts Clinical Outcomes in Children with Ulcerative ColitisKathryn Clarkston, Rebekah Karns, Anil G Jegga, et al.
Inflammatory Bowel Diseases|January 24, 2025
Circulating and Magnetic Resonance Imaging Biomarkers of Intestinal Fibrosis in Small Bowel Crohn's DiseaseJonathan R Dillman, Jean A Tkach, Joel G Fletcher, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Alimentary Pharmacology & Therapeutics|December 22, 2021
Antibodies-to-infliximab accelerate clearance while dose intensification reverses immunogenicity and recaptures clinical response in paediatric Crohn's diseaseRuben J Colman, Ye Xiong, Tomoyuki Mizuno, et al.
Inflammatory Bowel Diseases|May 23, 2024
Challenges in IBD Research 2024: Pragmatic Clinical ResearchJessica R Allegretti, Liliana G Bordeianou, Oriana M Damas, et al.
Alimentary Pharmacology & Therapeutics|October 31, 2022
Real world population pharmacokinetic study in children and young adults with inflammatory bowel disease discovers novel blood and stool microbial predictors of vedolizumab clearanceRuben J Colman, Tomoyuki Mizuno, Keizo Fukushima, et al.
Inflammatory Bowel Diseases|August 28, 2015
IL-33 Signaling Protects from Murine Oxazolone Colitis by Supporting Intestinal Epithelial FunctionAmanda Waddell, Jefferson E Vallance, Preston D Moore, et al.
Haematologica|February 2, 2023
Transcriptome analysis in acute gastrointestinal graft-<i>versus</i> host disease reveals a unique signature in children and shared biology with pediatric inflammatory bowel diseasePooja Khandelwal, Dana T Lounder, Allison Bartlett, et al.
Inflammatory Bowel Diseases|May 3, 2014
Utility of neutrophil Fcγ receptor I (CD64) index as a biomarker for mucosal inflammation in pediatric Crohn's diseasePhillip Minar, Yael Haberman, Ingrid Jurickova, et al.
European Radiology|March 23, 2025
Magnetic resonance imaging for suspected perianal Crohn's disease in children: a multi-reader agreement studyPradipta Debnath, Michael R Acord, Christopher G Anton, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 28, 2022
Multicenter Cohort Study of Infliximab Pharmacokinetics and Therapy Response in Pediatric Acute Severe Ulcerative ColitisKaitlin G Whaley, Ye Xiong, Rebekah Karns, et al.
Journal of Crohn'S & Colitis|June 6, 2022
Targeted Assessment of Mucosal Immune Gene Expression Predicts Clinical Outcomes in Children with Ulcerative ColitisKathryn Clarkston, Rebekah Karns, Anil G Jegga, et al.
Inflammatory Bowel Diseases|January 24, 2025
Circulating and Magnetic Resonance Imaging Biomarkers of Intestinal Fibrosis in Small Bowel Crohn's DiseaseJonathan R Dillman, Jean A Tkach, Joel G Fletcher, et al.
Pageof 5